Status:
UNKNOWN
Observational Study of Follow-up of Hospitalized Patients Diagnosed With COVID-19 to Evaluate the Effectiveness of the Drug Treatment Used to Treat This Disease. COVID-19 Registry
Lead Sponsor:
Instituto de Investigación Marqués de Valdecilla
Collaborating Sponsors:
Hospital Universitario Marqués de Valdecilla
Hospital Universitario de Canarias
Conditions:
SARS-CoV-2
Eligibility:
All Genders
1-100 years
Brief Summary
The infection caused by COVID19 worldwide makes it necessary to monitor drugs administered for the treatment of patients hospitalized with SARS-CoV-2. In order to know more about the efficacy and safe...
Eligibility Criteria
Inclusion
- Patients of any age and gender, including minors and pregnant women.
- Hospital admission with diagnosis of COVID-19 according to clinical and microbiological criteria established by the Health Authorities and clinical practice (these may be modified based on the "Technical Document. Clinical management of COVID-19: hospital care" of the Ministry of Health).
- Patients receiving any specific treatment for COVID-19 disease (according to the "Technical Document. Clinical management of COVID-19: medical treatment" of the Ministry of Health, and "Available treatments for the management of respiratory infection by SARS-CoV-2" of the AEMPS).
- Patients admitted but not receiving specific treatment for COVID-19 disease
Exclusion
- Patients who do not wish to give informed consent once requested.
Key Trial Info
Start Date :
April 22 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2022
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04347278
Start Date
April 22 2020
End Date
January 1 2022
Last Update
September 16 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario Marqués de Valdecilla
Santander, Cantabria, Spain, 39008